FindTrial
Sign In

Study on the role of bone endocrine factors in the occurrence of coronary stent restenosis

Study on the role of bone endocrine factors in the occurrence of coronary stent restenosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046048
Enrollment
Unknown
Registered
2021-05-02
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

control group:nothing
in-stent restenosis group:nothing

Sponsors

General Hospital of Western Theater Command of the People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: In-stent restenosis was confirmed by coronary angiography.

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction and stroke acute stage (<3 months); 2. Unable to cooperate (intelligence, hearing, physical activity obvious obstacles); 3. Complicated with serious diseases, life expectancy less than 1 year; 4. The individual is unwilling to participate the trial

Design outcomes

Primary

MeasureTime frame
ACTH;Dickkopf-1;FGF-23;Osteocalcin;Osteopontin;Osteoprotegerin;PTH;SOST;—

Countries

China

Contacts

Public ContactWang Ting

Three Gorges Hospital of Chongqing University

wantingchn@163.com+86 18030718037

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026